CWM
RPRX icon

CIBC World Markets’s Royalty Pharma RPRX Stock Holding History

CIBC World Markets’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$551K Buy
+14,250
New +$543K ﹤0.01% 814
2025
Q2 		$553K Sell
15,342
-1,842
-11% -$61K ﹤0.01% 834
2025
Q1 		$535K Sell
17,184
-53
-0.3% -$1.68K ﹤0.01% 978
2024
Q4 		$440K Sell
17,237
-5,156
-23% -$137K ﹤0.01% 778
2024
Q3 		$633K Buy
22,393
+1,920
+9% +$53.2K ﹤0.01% 662
2024
Q2 		$540K Buy
20,473
+4,928
+32% +$137K ﹤0.01% 651
2024
Q1 		$472K Buy
15,545
+4,915
+46% +$145K ﹤0.01% 725
2023
Q4 		$299K Buy
+10,630
New +$292K ﹤0.01% 701
2022
Q4 		– Sell
-550,000
Closed -$22.1M – 693
2022
Q3 		$22.1M Buy
+550,000
New +$23.5M 0.31% 42

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CIBC World Markets's RPRX Position: Q4 2025 in Review

CIBC World Markets opened a new position in Royalty Pharma (RPRX) in Q4 2025: 14,250 shares worth $551K. The stake represents ﹤0.01% of the portfolio and ranks #814 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in RPRX as recently as Q2 2025.

CIBC World Markets first reported a position in RPRX in Q3 2022 and has held it in 9 quarters since. The position peaked at $22.1M in Q3 2022. 538 funds tracked by Wall St. Rank hold RPRX as of Q4 2025.

  • CIBC World Markets held 14,250 shares of Royalty Pharma worth $551K as of Q4 2025.
  • Royalty Pharma was a new CIBC World Markets position in Q4 2025.
  • Royalty Pharma made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #814 holding.
  • CIBC World Markets first reported a position in Royalty Pharma in Q3 2022 and has held it in 9 quarters since.
  • CIBC World Markets's Royalty Pharma position peaked at $22.1M in Q3 2022.
  • 538 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.